UCB SA (UCB) - Medical Equipment - Deals and Alliances Profile

UCB SA (UCB) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME33857D
  • |
  • Pages: 40
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company's key medicines include Cimzia for ankylosing spondylitis, axial spondylarthritis, Crohn's disease, psoriatic arthritis and rheumatoid arthritis; Neupro for Parkinson's disease and restless legs syndrome; and Vimpat, Keppra and Briviact for epilepsy. UCB is also developing new therapies for neurological and immunological diseases. The company operates subsidiaries in the US, Japan, China, Germany, Italy, Spain, France, the UK, Ireland, Belgium, Brazil, Russia, India, Mexico, Turkey and other countries. UCB is headquartered in Brussels, Belgium.

UCB SA (UCB)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

UCB SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

UCB SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6

UCB SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

UCB SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

UCB SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

UCB SA, Medical Equipment, Deal Details 10

Venture Financing 10

Ceribell Raises USD35 Million in Series B Financing 10

Partnerships 11

Partners HealthCare System and UCB Enter into Agreement 11

MC10 Enters into Agreement with UCB 12

Evogen Enters into Agreement with UCB 13

MC10 Enters into Co-Development Agreement with UCB 14

Allium Medical Solutions Enters Into Distribution Agreement With Meizler UCB Biopharma For Urological Stents 15

King's College London Enters Into Licensing Agreement with UCB 16

Acquisition 17

Amphastar Pharma Acquires International Medication Systems from UCB Pharma for USD7.7 Million 17

UCB Acquires 51% Stake In Meizler Biopharma 18

UCB SA-Key Competitors 19

UCB SA-Key Employees 20

UCB SA-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Joint Venture 24

Recent Developments 25

Strategy And Business Planning 25

May 03, 2018: Science 37 Partners with UCB to Fundamentally Change the Clinical Trial Ecosystem, Focusing on More Patient-Friendly, Technology-Enabled Trials at Home 25

Financial Announcements 26

Jul 26, 2018: UCB half year report 2018: UCB continues its growth path 26

Apr 25, 2018: UCB First Three Months Interim Report 2018: UCB tracking well towards full year financial outlook 28

Feb 22, 2018: UCB Full Year Report 2017 30

Oct 20, 2017: UCB First Nine Months Interim Report 2017: Strong 9 months performance allows for increase of 2017 financial outlook 31

Jul 27, 2017: UCB with a strong first half year 2017-giving rise to the financial outlook for 2017 32

Apr 24, 2017: UCB First Three Months Interim Report 2017: UCB with a good start into 2017 35

Corporate Communications 36

Mar 24, 2017: UCB General Meeting on 27 April 2017 36

Other Significant Developments 37

May 07, 2018: Partnership with Science 37: helping UCB to improve patient experience 37

Apr 26, 2017: UCB Selects Medidata Clinical Cloud to Support Patient-Centric Drug Development 38

Jan 05, 2017: MC10 and UCB Complete Landmark Pharmaceutical / Technology Collaboration Evaluating Patient Monitoring in Parkinson's 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40

List of Figures

UCB SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

UCB SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

UCB SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

UCB SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

UCB SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

UCB SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

UCB SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

UCB SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

List of Tables

UCB SA, Medical Equipment, Key Facts, 2017 2

UCB SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

UCB SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

UCB SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6

UCB SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

UCB SA, Deals By Market, 2012 to YTD 2018 8

UCB SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Ceribell Raises USD35 Million in Series B Financing 10

Partners HealthCare System and UCB Enter into Agreement 11

MC10 Enters into Agreement with UCB 12

Evogen Enters into Agreement with UCB 13

MC10 Enters into Co-Development Agreement with UCB 14

Allium Medical Solutions Enters Into Distribution Agreement With Meizler UCB Biopharma For Urological Stents 15

King's College London Enters Into Licensing Agreement with UCB 16

Amphastar Pharma Acquires International Medication Systems from UCB Pharma for USD7.7 Million 17

UCB Acquires 51% Stake In Meizler Biopharma 18

UCB SA, Key Competitors 19

UCB SA, Key Employees 20

UCB SA, Subsidiaries 21

UCB SA, Joint Venture 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

UCB SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17958
Site License
USD 500 INR 35915
Corporate User License
USD 750 INR 53873

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com